Table 1.
Baseline patient characteristics
| n = 35 | |
|---|---|
| Age (mean ± SD), years | 66.2 ± 12 |
| Gender, male, n (%) | 29 (82.9) |
| ASA score (mean ± SD) | 2.1 ± 0.7 |
| Comorbid conditions, n (%) | |
| Cardiomyopathy | 9 (25.7) |
| COPD | 5 (14.3) |
| Liver cirrhosis | 3 (8.6) |
| Body mass index (mean ± SD), kg/m2 | 26.7 ± 5 |
| Anticoagulant or antiplatelet therapy, n (%) | 13 (37.1) |
| Previous therapeutic intervention on the esophagus, n (%) | |
| Endoscopic resection | 10 (28.6) |
| Argon plasma coagulation | 1 (2.9) |
| Radiofrequency ablation | 2 (5.7) |
| Radiotherapy | 1 (2.9) |
| Esophagectomy | 1 (2.9) |
| Barrett’s length (median, IQR), cm | |
| Circumferential extent (C) | 2.5 (1–5.5) |
| Maximal extent (M) | 5 (3–8) |
| Preoperative histology, n (%) | |
| Low grade dysplasia | 1 (2.9) |
| High grade dysplasia | 14 (38.9) |
| Adenocarcinoma | 21 (58.3) |
ASA: American Society of Anesthesiologists; COPD: chronic obstructive pulmonary disease; IQR: interquartile range.